Literature DB >> 19657480

Diagnostic algorithm for HBV safe transfusion.

Jean-Pierre Allain1, Daniel Candotti.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19657480      PMCID： PMC2719268          DOI： 10.2450/2008.0062-08

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  27 in total

1.  Immunoassay detection of hepatitis B surface antigen mutants.

Authors:  P F Coleman; Y C Chen; I K Mushahwar
Journal:  J Med Virol       Date:  1999-09       Impact factor: 2.327

2.  Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

Authors:  J P Allain; P E Hewitt; R S Tedder; L M Williamson
Journal:  Br J Haematol       Date:  1999-10       Impact factor: 6.998

3.  Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.

Authors:  Robin Biswas; Edward Tabor; Chu Chieh Hsia; David J Wright; Megan E Laycock; Eberhard W Fiebig; Lorraine Peddada; Richard Smith; George B Schreiber; Jay S Epstein; George J Nemo; Michael P Busch
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

4.  Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.

Authors:  A E Ling; K E Robbins; T M Brown; V Dunmire; S Y Thoe; S Y Wong; Y S Leo; D Teo; J Gallarda; B Phelps; M E Chamberland; M P Busch; T M Folks; M L Kalish
Journal:  JAMA       Date:  2000-07-12       Impact factor: 56.272

5.  Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Authors:  Susan L Stramer; Simone A Glynn; Steven H Kleinman; D Michael Strong; Sally Caglioti; David J Wright; Roger Y Dodd; Michael P Busch
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

6.  Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting.

Authors:  W K Roth; M Weber; E Seifried
Journal:  Lancet       Date:  1999-01-30       Impact factor: 79.321

7.  Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients.

Authors:  Snezna Levicnik-Stezinar; Urska Rahne-Potokar; Daniel Candotti; Nico Lelie; Jean-Pierre Allain
Journal:  J Hepatol       Date:  2008-03-28       Impact factor: 25.083

8.  Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.

Authors:  Daniel Candotti; Piotr Grabarczyk; Paola Ghiazza; Roberto Roig; Natalia Casamitjana; Paola Iudicone; Michael Schmidt; Arthur Bird; Robert Crookes; Ewa Brojer; Michelina Miceli; Azin Amiri; Chengyao Li; Jean-Pierre Allain
Journal:  J Hepatol       Date:  2008-06-02       Impact factor: 25.083

9.  A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection.

Authors:  K Satoh; A Iwata-Takakura; A Yoshikawa; Y Gotanda; T Tanaka; T Yamaguchi; H Mizoguchi
Journal:  Vox Sang       Date:  2008-10       Impact factor: 2.144

10.  Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.

Authors:  Daniel Candotti; Jillian Temple; Shirley Owusu-Ofori; Jean-Pierre Allain
Journal:  J Virol Methods       Date:  2004-06-01       Impact factor: 2.014
View more
  23 in total

Review 1.  Molecular virology in transfusion medicine laboratory.

Authors:  Daniel Candotti; Jean-Pierre Allain
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

2.  Occult hepatitis B infection among blood donors from Yaoundé, Cameroon.

Authors:  Diderot Fopa; Daniel Candotti; Claude T Tagny; Camille Doux; Dora Mbanya; Edward L Murphy; Hany I Kenawy; Farha El Chenawi; Syria Laperche
Journal:  Blood Transfus       Date:  2019-11       Impact factor: 3.443

3.  Hepatitis B escape mutants in Scottish blood donors.

Authors:  Osmany Larralde; Brian Dow; Lisa Jarvis; Fiona Davidson; Juraj Petrik
Journal:  Med Microbiol Immunol       Date:  2012-12-29       Impact factor: 3.402

Review 4.  Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing.

Authors:  Antonella Esposito; Chiara Sabia; Carmela Iannone; Giovanni F Nicoletti; Linda Sommese; Claudio Napoli
Journal:  Transfus Med Hemother       Date:  2017-05-05       Impact factor: 3.747

5.  Performance characteristics and comparison of Abbott and artus real-time systems for hepatitis B virus DNA quantification.

Authors:  Ashrafali M Ismail; Jayashree Sivakumar; Raghavendran Anantharam; Sujitha Dayalan; Prasanna Samuel; Gnanadurai J Fletcher; Manu Gnanamony; Priya Abraham
Journal:  J Clin Microbiol       Date:  2011-07-27       Impact factor: 5.948

Review 6.  Diagnostic strategy for occult hepatitis B virus infection.

Authors:  Sara Ocana; Maria Luisa Casas; Ingrid Buhigas; Jose Luis Lledo
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 7.  Screening and diagnosis of HBV in low-income and middle-income countries.

Authors:  Jean-Pierre Allain; Ohene Opare-Sem
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

Review 8.  Hepatitis B transmission by cell and tissue allografts: how safe is safe enough?

Authors:  Pilar Solves; Vicente Mirabet; Manuel Alvarez
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.

Authors:  Luisa Romanò; Claudio Velati; Giuseppe Cambiè; Laura Fomiatti; Claudio Galli; Alessandro Remo Zanetti
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

10.  Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country.

Authors:  Martin Stolz; Peter Gowland; Caroline Tinguely; Christoph Niederhauser
Journal:  Transfus Med Hemother       Date:  2019-03-12       Impact factor: 3.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.